BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 3372679)

  • 1. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size.
    Burris AS; Rodbard HW; Winters SJ; Sherins RJ
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1144-51. PubMed ID: 3372679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up.
    Vicari E; Mongioì A; Calogero AE; Moncada ML; Sidoti G; Polosa P; D'Agata R
    Int J Androl; 1992 Aug; 15(4):320-9. PubMed ID: 1516981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
    Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
    Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Testicular findings, endocrine features and therapeutic responses of men with idiopathic hypogonadotropic hypogonadism].
    Tachiki H; Kumamoto Y; Itoh N; Maruta H; Tsukamoto T
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):605-22. PubMed ID: 7796925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
    Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T; Wikström AM; Dunkel L
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
    Liu L; Chaudhari N; Corle D; Sherins RJ
    Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
    Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
    Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism.
    Finkel DM; Phillips JL; Snyder PJ
    N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
    Guo CY; Jones TH; Eastell R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of deoxyribonucleic acid fragmentation index, testicular volume, semen parameters, and hormone profile in gonadotropin-treated men with hypogonadotropic hypogonadism.
    Hosseinifar H; Sabbaghian M; Chehrazi M; Modarresi T; Alipour FJ; Sadighi Gilani MA
    Urology; 2013 Dec; 82(6):1291-5. PubMed ID: 24094652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
    Christiansen P; Skakkebaek NE
    Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.